Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Assertio Therapeutics ( (ASRT) ) just unveiled an announcement.
On December 19, 2025, Assertio Holdings, Inc. filed an amendment to its certificate of incorporation to implement a 1-for-15 reverse stock split of its common stock, which had been approved by shareholders at the annual meeting on May 7, 2025. The reverse split will take effect at 12:01 a.m. Eastern Time on December 26, 2025, with ASRT shares beginning to trade on a split-adjusted basis that day under the same Nasdaq ticker but with a new CUSIP, consolidating every 15 existing shares into one new share, paying cash in lieu of fractional shares based on the December 24, 2025 closing price, and proportionately adjusting the conversion rate on its 6.5% Convertible Senior Notes due 2027 as well as all equity incentive plan instruments, while leaving the par value per share unchanged.
The most recent analyst rating on (ASRT) stock is a Hold with a $0.79 price target. To see the full list of analyst forecasts on Assertio Therapeutics stock, see the ASRT Stock Forecast page.
Spark’s Take on ASRT Stock
According to Spark, TipRanks’ AI Analyst, ASRT is a Neutral.
Assertio Therapeutics’ overall stock score reflects a challenging financial performance with negative profitability and cash flow issues. While technical indicators are mixed, the earnings call provided some positive insights into sales growth and strategic initiatives. Recent corporate events are seen as positive steps towards improving the company’s future prospects. However, the negative valuation metrics and ongoing challenges in profitability weigh heavily on the overall score.
To see Spark’s full report on ASRT stock, click here.
More about Assertio Therapeutics
Assertio Holdings, Inc. is a specialty pharmaceutical company whose common stock trades on the Nasdaq Stock Market under the symbol “ASRT,” focusing on commercial-stage therapeutics and related equity and debt financing instruments.
Average Trading Volume: 397,589
Technical Sentiment Signal: Strong Sell
Current Market Cap: $69.3M
For detailed information about ASRT stock, go to TipRanks’ Stock Analysis page.